Overcoming antigenic diversity and improving vaccines using DNA shuffling and screening technologies

Area of Science:

• Immunology and Vaccinology
• Molecular Biology
• Pathogen Evolution

Background:

• Pathogens evolve strategies like antigenic variation to evade host immune responses, hindering vaccine development.
• Current vaccine candidates often target limited antigen variants or require complex multivalent formulations.
• Antigenic variation reduces the binding affinity of antigens to antibodies and MHC molecules, complicating immune recognition.

Purpose of the Study:

• To explore the application of DNA shuffling and screening technologies for developing novel vaccine candidates.
• To identify vaccine candidates that can elicit immune responses against multiple antigenic variants.
• To select vaccine candidates with enhanced immunogenicity and improved production characteristics.

Main Methods:

• Utilizing DNA shuffling and screening (Molecular Breeding) for directed molecular evolution.
• Developing novel and chimeric vaccine candidates.
• Evaluating immune responses to vaccine candidates targeting multiple antigenic variants.

Main Results:

• DNA shuffling successfully identified and developed novel and chimeric vaccine candidates.
• These candidates induce immune responses capable of recognizing and controlling multiple antigenic variants.
• Selected candidates demonstrated improved immunogenicity, increased recombinant polypeptide expression, and enhanced viral growth.

Conclusions:

• DNA shuffling is a powerful tool for developing broad-spectrum vaccine candidates against diverse pathogens.
• This technology addresses key challenges in vaccine development, including antigenic variation and manufacturing.
• Numerous applications exist for DNA shuffling in optimizing vaccine design and production processes.